Structure and Immune Recognition of HLA-B27 Antigens: Implications for Disease Association

References

• Brewerton D A, Caffrey M, Hart F D, James D CO, Nicholls A, Sturrock RD. Ankylosing spondylitis and HL-A27. Lancet 1973; 1: 904–7
   PubMed Web of Science ®Google Scholar
• Schlosstein L, Terasaki P I, Bluestone R, Pearson CM. High association of HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–6
   PubMed Web of Science ®Google Scholar
• Coppin H C, McDevitt HO. Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 1986; 137: 2168–72
   Google Scholar
• de Castro López JA. HLA-B27 and HLA-A2 subtypes: Structures, evolution and function. Immunol Today 1989; 10: 239–46
   Google Scholar
• Choo S Y, Hansen JA. A novel HLA-Class I allele derived from a recombination between B2705 and Bw61. Human Immunology Program and Abstracts. Elsevier, 1989, (15th Annual ASHI Meeting) Abstr. 4.2-02
   Google Scholar
• Bjorkman P J, Saper M A, Samraui B, Bennett W S, Strominger J L, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506–12
   PubMed Web of Science ®Google Scholar
• Bjorkman P J, Saper M A, Samraui B, Bennett W S, Strominger J L, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–18
   PubMed Web of Science ®Google Scholar
• Garrett T PJ, Saper M A, Bjorkman P J, Strominger J L, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 692–96
   PubMed Web of Science ®Google Scholar
• Bjorkman P J, Parham P. Structure, function and diversity of Class I major histocompatibility molecules. Ann Rev Biochem 1990, In press
   Google Scholar
• Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 134–42
   Google Scholar
• Ezquerra A, Bragado R, Vega M, Strominger J L, Woody J, de Castro López JA. Primary structure of papain-solubilized human histocompatibility antigen HLA-B27. Biochemistry 1985; 24: 1733–41
   Google Scholar
• Toubert A, Raffoux C, Boretto J, Sire J, Sodoyer R, Thurau S R, Amor B, Colombani J, Lemonnier F A, Jordan BR. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants. J Immunol 1988; 141: 2503–9
   PubMed Web of Science ®Google Scholar
• El-Zaatari F AK, Sams K C, Taurog JD. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position u7 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain. J Immunol 1990; 144: 1512–17
   PubMed Web of Science ®Google Scholar
• De Waal L P, Krom F EJM, Breur-Vriesendorp B S, Engelfriet C P, de Castro López J A, Ivanyi P. Conventional alloantisera can recognize the same HLA-B27 polymorphism as detected by cytotoxic T lymphocytes. Human Immunol 1987; 20: 265–71
   Google Scholar
• Rojo S, de Castro López J A, Aparicio P, van Seventer G, Bragado R. HLA-B27 antigenicity: Antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes. J Immunol 1986; 137: 904–10
   Google Scholar
• Choppin J, Metzger J J, Bouillot M, Briand J P, Connan F, van Regenmortel M HV, Levy JP. Recognition of HLA class I molecules by antisera directed to synthetic peptides corresponding to different regions of HLA-B7 heavy chain. J Immunol 1986; 136: 1738–44
   Google Scholar
• Vega M A, Wallace L, Rojo S, Bragado R, Aparicio P, de Castro JA. Lopez. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes. J Immunol 1985; 135: 3323–32
   Google Scholar
• Choo S Y, John T S, Orr H T, Hansen JA. Molecular analysis of the variant alloantigen HLA B27d (HLA-B-2703) identifies a unique single amino acid substitution. Hum Immunol 1988; 21: 209–19
   Google Scholar
• Breur-Vriesendorp B S, Dekker-Saeys A J, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987; 46: 353–6
   PubMedGoogle Scholar
• Jaraquemada D, Galocha B, Aparicio P, Rojo S, Calvo V, de Castro López JA. Modulation on immunogenicity by HLA-B27 subtype polymorphism. Eur J Immunol 1988; 180: 1945–50
   Google Scholar
• Calvo V, Rojo S, Lopez D, Galocha B, de Castro Lopez JA. Structure and diveristy of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990; 144: 4038–415
   Google Scholar
• Bragado R, Lauzurica P, López D, de Castro López JA. T cell receptor Vβ gene usage in a human alloreactive response: Shared structural features among HLA-B27-specific T cell clones. J Exp Med 1990; 171: 1189–204
   PubMed Web of Science ®Google Scholar
• Hedrick S M, Engel I, McElligot D L, Fink P J, Hsu M, Hansburg D, Matis LA. Selection based on specificity for amino acid sequences in the putative third hypervariable region of the beta chain of the T cell antigen receptor. Science 1988; 239: 1541–4
   PubMed Web of Science ®Google Scholar
• Acha-Orbea H, Mitchell D, Timmermann L, Wraith D C, Tausch G S, Waldor MK. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988; 54: 263–73
   PubMed Web of Science ®Google Scholar
• Engel I, Hedrick SM. Site-directed mutations in the VDJ junctional region of a T cell receptor β chain cuase changes in antigenic peptide recognition. Cell 1988; 54: 473–84
   PubMed Web of Science ®Google Scholar